What does CUSIP 03969F109 represent in this 13F holders report?

CUSIP 03969F109 is the security identifier for RCUS - Arcus Biosciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RCUS - Arcus Biosciences, Inc. - Common Stock in Q2 2023?

177 institutional investors reported RCUS - Arcus Biosciences, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Arcus Biosciences, Inc. - Common Stock (RCUS)

CUSIP: 03969F109

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 122,470,452
Total 13F shares: 54,702,646
Share change: -674,004
Total reported value: $1,110,123,478
Put/Call ratio: 62%
Price per share: $20.31
Number of holders: 177
Value change: -$11,409,103
Number of buys: 81
Number of sells: 87

Quarterly Holders Quick Answers

What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 03969F109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	8.3%	10,139,020	$184,935,726	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	4.5%	5,496,253	$100,251,248	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	3.6%	4,423,659	$80,687,540	—	31 Mar 2023	13F
FMR LLC	13F	Company	2.7%	3,309,836	$60,371,409	—	31 Mar 2023	13F
Octagon Capital Advisors LP	13F	Company	1.8%	2,172,000	$39,617,280	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.4%	1,766,008	$32,211,986	—	31 Mar 2023	13F
Invus Financial Advisors, LLC	13F	Company	1.3%	1,612,077	$29,404,284	—	31 Mar 2023	13F
PFM Health Sciences, LP	13F	Company	1.3%	1,559,947	$28,453,433	—	31 Mar 2023	13F
Boxer Capital, LLC	13F	Company	1.2%	1,432,200	$26,123,000	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.1%	1,307,077	$23,839,290	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	1%	1,283,843	$23,417,296	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.94%	1,149,218	$20,961,737	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.83%	1,017,929	$18,567,025	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.8%	978,167	$17,841,772	—	31 Mar 2023	13F
Decheng Capital Management III (Cayman), LLC	13F	Company	0.71%	869,790	$15,864,970	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.66%	804,534	$14,674,700	—	31 Mar 2023	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.63%	774,792	$14,132,000	—	31 Mar 2023	13F
Granahan Investment Management, LLC	13F	Company	0.47%	576,748	$10,519,884	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.45%	556,081	$10,142,919	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.44%	539,995	$9,850,000	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.43%	530,975	$9,684,985	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.39%	478,400	$8,726,016	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.36%	441,241	$8,048,000	—	31 Mar 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.35%	427,212	$7,792,000	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.34%	421,691	$7,691,644	—	31 Mar 2023	13F
Walleye Capital LLC	13F	Company	0.34%	415,687	$7,582,131	—	31 Mar 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.34%	411,300	$7,502,112	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.34%	410,992	$7,496,494	—	31 Mar 2023	13F
MACQUARIE GROUP LTD	13F	Company	0.31%	379,100	$6,915,000	—	31 Mar 2023	13F
Verition Fund Management LLC	13F	Company	0.29%	357,986	$6,529,665	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.29%	351,936	$6,419,312	—	31 Mar 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.27%	324,740	$5,923,257	—	31 Mar 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.24%	293,810	$5,359,093	—	31 Mar 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.24%	293,646	$5,356,103	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.23%	283,119	$5,164,090	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.23%	279,530	$5,100,000	—	31 Mar 2023	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.22%	265,064	$4,834,767	—	31 Mar 2023	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.21%	263,086	$4,813,158	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.21%	262,120	$4,781,068	—	31 Mar 2023	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.21%	252,984	$4,614,428	—	31 Mar 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.2%	240,000	$4,377,600	—	31 Mar 2023	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.19%	232,612	$4,242,843	—	31 Mar 2023	13F
Ikarian Capital, LLC	13F	Company	0.19%	230,000	$4,195,200	—	31 Mar 2023	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.19%	228,111	$4,160,748	—	31 Mar 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.18%	221,257	$4,035,728	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.18%	218,381	$3,983,269	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.16%	195,035	$3,557,438	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.14%	175,217	$3,195,958	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.14%	166,081	$3,029,000	—	31 Mar 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.13%	163,296	$2,978,519	—	31 Mar 2023	13F

Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q2 2023

As of 30 Jun 2023, Arcus Biosciences, Inc. - Common Stock (RCUS) was held by 177 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,702,646 shares. The largest 10 holders included BlackRock Inc., FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, Octagon Capital Advisors LP, Balyasny Asset Management L.P., Invus Financial Advisors, LLC, Boxer Capital, LLC, AMERIPRISE FINANCIAL INC, and PFM Health Sciences, LP. This page lists 177 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

177

Q2 2023 holders

177

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.